Gemcitabine in the treatment of metastatic pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Gemcitabine in the treatment of metastatic pancreatic cancer.

Gemcitabine in the treatment of metastatic pancreatic cancer.

http://www.wikidata.org/entity/Q37134412

about

Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease.Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells.Preclinical absorption, distribution, metabolism, and excretion of an oral amide prodrug of gemcitabine designed to deliver prolonged systemic exposure.Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.

P2860

Q28485457-4E9C0EE2-3FE7-4AFE-BF3B-65AB20AC1CCB Q33713383-B1D603DD-DFD1-40BE-9AC0-F11D9554A3C9 Q35558002-8C41B9C6-2AB6-4DE1-8FF9-B7843C325FFC Q36721737-4601B611-FD49-4C8D-8374-BD0B3475EC18 Q37182951-12BF859E-FB33-4B14-8EEA-A9734276855E Q37327880-CF7B2A2B-9ABD-439C-86B1-BBF11773969E Q38787316-C7996C0D-1B64-4616-96BD-9D220572F0A5 Q38811077-99DFEC98-3D9E-4722-8B59-B4E5905ACFE7 Q39014487-07E31968-6427-46CE-A304-44930AFCC167 Q50553669-699173FD-F481-478C-A53D-07FD17CC7DEB

P2860

Gemcitabine in the treatment of metastatic pancreatic cancer.

http://www.wikidata.org/entity/Q37134412

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gemcitabine in the treatment of metastatic pancreatic cancer.

@en

Gemcitabine in the treatment of metastatic pancreatic cancer.

@nl

type

label

Gemcitabine in the treatment of metastatic pancreatic cancer.

@en

Gemcitabine in the treatment of metastatic pancreatic cancer.

@nl

prefLabel

Gemcitabine in the treatment of metastatic pancreatic cancer.

@en

Gemcitabine in the treatment of metastatic pancreatic cancer.

@nl

P1433

Q37134412-DA0CA403-A7F4-4146-9300-5BD738190F84

P1476

Q37134412-E3825734-4949-4E51-87B2-0DF7C8BF3BB1

P2093

Q37134412-49B958CC-DCDC-4F41-B1BC-802C3C76671D

Q37134412-4A55811E-C3E5-4869-A7A1-1434669228C4

P2860

Q37134412-008AC524-C694-4C89-A5E6-7846DB686A84

Q37134412-0367B287-5E50-431E-AC8A-B852B6566088

Q37134412-04517713-04E0-4190-9EB1-6664A75C93F1

Q37134412-0BDB3098-D9DF-43A4-8BD9-C971C70C0974

Q37134412-18BF81D7-A19B-4108-B116-174CAA0DDBD3

Q37134412-19FD56C6-8C05-4C0D-A2A2-2CF927C5686C

Q37134412-1ED03679-FA02-4FAD-B503-5262A67C2719

Q37134412-21138A11-0237-48D7-B25E-8CC159163CBE

Q37134412-232A8EB6-9576-4B20-8EEC-FBAEAECA0854

Q37134412-2713FED8-4624-4F90-BFBD-C18F2032260E

P304

Q37134412-C088DFD1-47AF-4C36-864E-CEF444A8F0E0

P31

Q37134412-F1182D91-C252-40DB-B1BA-CF2D3A22734F

P356

Q37134412-F4DBF4C1-1A6C-402C-844D-DEE3E6327AFC

P433

Q37134412-D9E64600-E6C2-48A6-97F3-A6D4EFDAADF2

P478

Q37134412-EBE13FAB-FDF0-45DA-B190-CCEA47C836B5

P577

Q37134412-EAC3DC0E-1A84-4AC5-A02B-7CD851293E9C

P698

Q37134412-3F688650-1FDC-4029-9603-E954F390783A

P356

14737140.8.4.511

P1433

Expert Review of Anticancer Therapy

P1476

Gemcitabine in the treatment of metastatic pancreatic cancer.

@en

P2093

Andreas Hilbig

http://www.w3.org/2001/XMLSchema#string

Helmut Oettle

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis: targets in pancreatic cancer

Pathways for aberrant angiogenesis in pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.

Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan

Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer.

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer.

P304

511-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.4.511

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18402518

http://www.w3.org/2001/XMLSchema#string